9 oct 2018
CPhI Worldwide 2018
Catalent

Catalent

Exhibitor at CPhI Worldwide 2018 stand 3D10, ICSE General Floor

About us

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has the proven expertise, superior technologies and flexible solutions at the right scale to help ensure successful product development, launch, tech transfer and global reliable supply. Our team of nearly 13,000, including approximately 2,400 scientists at over 35 sites, develops more than 700 projects and helps launch over 200 products every year. We produce +72 billion doses of +7,000 products for more than 1,000 customers – or 1 in 20 doses taken by patients globally. We partner with 87 of the top 100 global pharmaceutical marketers, to 24 of 25 biological marketers, to 21 of 25 leading consumer health marketers, to thousands of small innovators globally. Our passion is to help unlock the full potential of your product.

More products better treatments reliably supplied ™


Specs about this supplier

Sales markets Western Europe; Eastern Europe; Asia; Australia; North America; Central/South America
Affiliated categories: Analytical Development |Antibody Drug Conjugates (ADCs) |API Contract Manufacturing More

Pharma Insight Briefings

Pharma & OTC: Entering the most prosperous emerging markets

11:50 - 12:20 ICSE Theatre

With the ever increasing global competition that Pharma & OTC companies are facing, more and more firms are turning to the Emerging Markets where growth rates are significantly higher than those in the mature markets. The growth potential of these regions offer attractive internationalization opportunities for foreign Pharma & OTC companies. Countries in Asia, Middle East, Latin America and the CIS region are particularly interesting for foreign Pharma & OTC companies looking to geographically expand. One example is Mexico, which has the second largest pharmaceutical market in Latin America. Internationalizing into the Emerging Markets is not a straight forward process. With the example of Mexico, the registration process can be lengthy and complex. We find that applying a systematic approach to internationalization improves the efficiency and success rate of the process.Throughout this session, the opportunities for Pharma & OTC companies in the Emerging Markets will be discussed and strategies for approaching new markets will be explained. Additionally, a case study will be presented on the Mexican cough & cold market.

More Information

Products featured at CPhI Worldwide 2018

Catalent

Event information

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain Visit us at stand 3D10